Summit Creek Advisors LLC Acquires Shares of 85,118 Addus HomeCare Corporation $ADUS

Key Points

• Summit Creek Advisors acquired 85,118 shares of Addus HomeCare, valued at approximately $8.55 million, making ADUS its fifth-largest holding and representing about 0.46% of the company.
• Institutional investors own 95.35% of Addus HomeCare, with major holders including BlackRock, Capital Research, Vanguard, Wasatch Advisors and Dimensional Fund Advisors.
• Addus reported quarterly EPS of $1.73, exceeding estimates by $0.03, while revenue rose 8% year over year to $377.41 million. Analysts give the stock a “Moderate Buy” consensus rating with an average price target of $130.88.

Summit Creek Advisors LLC acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 85,118 shares of the company's stock, valued at approximately $8,552,000. Addus HomeCare makes up 2.9% of Summit Creek Advisors LLC's portfolio, making the stock its 5th largest holding. Summit Creek Advisors LLC owned about 0.46% of Addus HomeCare at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. BlackRock Inc. bought a new stake in Addus HomeCare in the second quarter valued at about $344,153,000. Capital Research Global Investors increased its holdings in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company's stock valued at $157,837,000 after acquiring an additional 268,192 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Addus HomeCare by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company's stock valued at $140,531,000 after acquiring an additional 10,501 shares in the last quarter. Wasatch Advisors LP lifted its stake in Addus HomeCare by 0.8% during the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company's stock worth $110,467,000 after purchasing an additional 7,089 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock worth $69,689,000 after purchasing an additional 78,415 shares during the last quarter. Institutional investors own 95.35% of the company's stock.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the company's stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ADUS has been the subject of several recent research reports. Barclays boosted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research note on Wednesday, July 8th. Citigroup reaffirmed a "market outperform" rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings upgraded shares of Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 9th. Citizens Jmp reiterated a "market outperform" rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Finally, Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $130.88.

Addus HomeCare Stock Performance

ADUS stock opened at $118.13 on Wednesday. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of 20.72, a PEG ratio of 1.56 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The stock's fifty day moving average is $107.83 and its two-hundred day moving average is $102.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same quarter in the prior year, the firm earned $1.49 earnings per share. The company's quarterly revenue was up 8.0% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Corporation will post 6.29 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source